Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Spire Healthcare ( (GB:SPI) ) has issued an announcement.
Spire Healthcare Group PLC announced that its Executive Directors, Justin Ash and Harbant Samra, have exercised their options under the 2022 Sharesave Plan, acquiring 1,818 shares each at an exercise price of £1.98 per share. This transaction reflects the directors’ continued confidence in the company’s growth and stability, as all acquired shares have been retained, potentially strengthening their alignment with shareholder interests.
The most recent analyst rating on (GB:SPI) stock is a Buy with a £2.90 price target. To see the full list of analyst forecasts on Spire Healthcare stock, see the GB:SPI Stock Forecast page.
Spark’s Take on GB:SPI Stock
According to Spark, TipRanks’ AI Analyst, GB:SPI is a Outperform.
Spire Healthcare’s stock score is driven by strong financial performance, particularly in revenue growth and operational efficiency, despite high leverage and modest net margins. Technical indicators show positive momentum, supporting a favorable outlook. Corporate events contribute positively with strategic initiatives and strong governance, but the high P/E ratio suggests a need for valuation caution.
To see Spark’s full report on GB:SPI stock, click here.
More about Spire Healthcare
Spire Healthcare Group PLC operates in the healthcare industry, providing a range of private healthcare services across the UK. The company focuses on delivering high-quality medical care through its network of hospitals and clinics.
Average Trading Volume: 988,423
Technical Sentiment Signal: Hold
Current Market Cap: £841M
For a thorough assessment of SPI stock, go to TipRanks’ Stock Analysis page.